Several studies show that C-type natriuretic peptide (CNP) has a modulatory role in the digestive system. CNP administration reduces both jejunal fluid and bile secretion in the rat. In the present study we evaluated the effect of CNP on amylase release in isolated pancreatic acini as well as the receptors and intracellular pathways involved. Results showed that all natriuretic peptide receptors were expressed not only in the whole pancreas but also in isolated pancreatic acini. CNP stimulated amylase secretion with a concentration-dependent biphasic response; maximum release was observed at 1pM CNP whereas higher concentrations gradually attenuated it. The response was mimicked by a selective NPR-C agonist, and inhibited by pertussis toxin, strongly supporting NPR-C receptor activation. CNP-evoked amylase release was abolished by U-73122 (PLC inhibitor) and 2-APB (IP 3 receptor antagonist), partially inhibited by GF-109203X (PKC 
Introduction
C-type natriuretic peptide (CNP), a 22-amino acid peptide, is a member of the natriuretic peptide family also including atrial natriuretic peptide (ANF) and B-type natriuretic peptide (BNP). CNP is regarded as an endothelium-derived vasodilator and plays an important role in the control of both vascular tone and vascular remodeling process (4) . CNP has considerable sequence homology with ANF and BNP, including a 17-membered disulfide ring structure, essential for the biological activity, but lacks the carboxyl-terminal extension beyond the 17-amino acid-ring which results in weak diuretic and natriuretic properties compared with the other family members (28, 32) . Both ANF and BNP are predominantly synthesized and released by cardiac myocytes where they are stored in granules and released by mechanical (atrial stretch) or neuroendocrine stimuli (endothelin-1 or -adrenergic stimulation) (8) . CNP was first reported in the porcine brain (31) but later studies showed that it is synthesized by endothelial cells as well as by noncardiac tissues (15) .
Molecular cloning techniques revealed the existence of three natriuretic peptide receptors (NPR-A, NPR-B and NPR-C) that are widely distributed and display distinct affinities for the members of the natriuretic peptide family (1) . CNP preferentially binds to NPR-B and NPR-C (32) . The NPR-A and NPR-B receptors, that mediate most of the renal and cardiovascular effects of the natriuretic peptides, are membrane guanylyl cyclases with a tyrosine kinase-like domain (34). The NPR-C receptor displays similar affinity for all the natriuretic peptides but exhibits distinct structural properties. It was originally considered a clearance receptor, but later studies revealed that it is a G protein coupled receptor (GPCR) (2) . Its intracellular domain is devoid of guanylyl cyclase and kinase activities and it is coupled to adenylyl cyclase (AC) inhibition through an inhibitory guanine nucleotide Page 3 of 37 regulatory protein (G i ) and/or to phospholipase C (PLC) activation (2, 17) . This receptor subtype coupled to G i-1 and G i-2 is the predominant natriuretic peptide receptor in visceral and vascular smooth muscle cells (17) . The mRNAs of natriuretic peptide receptors have been shown in diverse tissues as the heart, brain, kidney, stomach and salivary glands among others (2, 12, 15, 17, 28, 34) . Although previous binding as well as functional studies support the expression of the three natriuretic peptide receptors in the pancreas (10, 24, 27) their mRNAs have not been reported in this gland so far.
CNP plays a relevant role in blood pressure regulation but it also participates in the modulation of digestive function (4, 35) . We have previously reported that CNP is involved in the central as well as peripheral regulation of bile secretion in the rat (25, 26) . The intravenous administration of CNP reduces bile secretion by decreasing bile acid output through the activation of NPR-C receptors (26) . When the peptide is applied to the brain it also reduces bile flow without the participation of the autonomic nervous system, supporting the role of peptidergic pathways (25) . CNP not only reduces bile secretion but it also diminishes intestinal secretion (16) . However, when CNP is centrally applied it stimulates pancreatic fluid and protein output through vagal pathways by the activation of central NPR-A and /or NPR-B receptors (23).
In the present study we sought to establish the effect of CNP on amylase release in isolated pancreatic acini and the receptors as well as the intracellular signaling mechanisms involved. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis showed the expression of the three natriuretic peptide receptors not only in the whole pancreas but also in isolated pancreatic acini. Furthermore, CNP stimulated amylase secretion through NPR-C receptors coupled to the PLC pathway showing a concentration-dependent biphasic response similar to that elicited by known pancreatic secretagogues. The maximum amylase release was achieved at 1 pM CNP, then higher concentrations attenuated the response in parallel with a decrease in cAMP content and an increase in cGMP levels.
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Materials and Methods
Sprague Dawley strain rats weighing between 250 and 300 g bred in Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, were used in the experiments. They were housed in steel cages and maintained at 22-24 ºC in a controlled room with 12-h light/dark cycle (light from 7:00 to 19:00 h). All experiments were conducted following the recommendations of the National Institutes of Health guidelines for the care and use of laboratory animals (NIH Publication N85-23, 1985, revised 1996 
Expression of natriuretic peptide receptors
The expression of natriuretic peptide receptors (NPR-A, NPR-B and NPR-C) in rat brain, heart, pancreas and pancreatic acini was assessed by RT-PCR. As the gene expression of natriuretic peptide receptors was reported in brain and heart, these tissues were used as positive controls (2, 28) . The following primers were used: rat NPR-A: 5'-GCGTGGTAGATGGACGTTTT-3' (sense), 5'-GGCAATTTCCTGAAGGATGA-3' 
Studies in isolated pancreatic acini -Preparation of isolated pancreatic acini
Isolated pancreatic acini were obtained as previously described (36, 24, 27 -cAMP and cGMP determination
The accumulation of cAMP was assessed as previously described (7, 24) . Briefly, acini were preincubated for 30 min at 37°C and then incubated for 3 min in fresh Krebs solution containing 1 mM IBMX and then for 12 min with CNP. Experiments were also carried out in the presence of 10 µM U-73122, 100 nM GF-109203X, 2 µM KT-5823, 10 µM L-NAME to inhibit PLC, PKC, PKG and nitric oxide synthase activities, respectively.
Inhibitors were added 5-10 min before the addition of the peptide. Reaction was stopped by homogenization in ice-cold ethanol and centrifuged for 15 min at 1,200 g. The supernatant was dried and the residue suspended for cAMP determination that was assessed by competition of [ 3 H] cAMP for PKA as previously detailed (7). The content of cGMP was determined by radioimmunoassay as previously detailed (29) . All cyclic nucleotides were expressed as picomoles per milligram protein.
Phosphoinositide hydrolysis measurement
Phosphoinositide turnover was determined as previously detailed (5, 27) . Briefly, isolated pancreatic acini were incubated in KHB containing 10 mM LiCl and 4 µCi/ml myo- 
Statistical analysis
Results are expressed as the mean ± SEM. The statistical analysis was performed by ANOVA followed by the Student-Newman-Keuls test. A p of 0.05 or less was considered statistically significant.
Results
Binding, pharmacological and functional studies support that natriuretic peptide receptors are expressed in the pancreas (10, 24, 27) . In the present work we demonstrated by RT-PCR that NPR-A, NPR-B and NPR-C were all expressed not only in the whole pancreas, but also in isolated pancreatic acini (Fig. 1) . NPR-A, NPR-B and NPR-C primers yielded products of the expected size (203, 223 and 208 bp, respectively). In addition, a semi-quantitative approach was also performed by analyzing the PCR products at 28 and 32
cycles to compare the relative abundance of these transcripts between the whole pancreas and pancreatic acini. As no differences were found it strengthens the identification of natriuretic peptide receptors on acinar cells (data not shown).
CNP concentration-dependently stimulated amylase release from isolated pancreatic acini showing a biphasic response similar to that of the pancreatic secretagogue CCK (Fig.   2 ). CNP at 0.1 pM enhanced amylase release reaching a maximum (230 %) at 1 pM CNP; at higher concentrations the stimulatory response was gradually decreased although it remained elevated compared with non-stimulated or basal release (3.5±0.3%) (Fig.2) .
The selective agonist of NPR-C receptors, cANP (4-23 amide), mimicked CNP effect showing a similar biphasic response, although the peak was achieved at a higher concentration than that of CNP (Fig. 3) . However, the maximum amylase release was similar for both CNP and the selective agonist (Fig. 3, inset) . The incubation of acini with CNP and cANP (4-23 amide) combined did not further increase the enzyme output (data not shown). Furthermore, pretreatment of the acini with pertussis toxin abolished CNPevoked amylase release (Fig. 4) . These findings strongly support that the increase in amylase output induced by CNP was mediated by NPR-C receptors.
We next conducted experiments in order to investigate whether muscarinic, CCK and VPAC receptors or nitric oxide were involved in CNP response. Blockade of muscarinic, CCK and VPAC receptors or the inhibition of nitric oxide synthase failed to affect basal or CNP-evoked pancreatic amylase release supporting that neither these receptors nor nitric oxide were involved in CNP stimulatory effect on amylase output (Fig.   5 ).
The major pancreatic secretagogues that evoke amylase release signal through the activation of PLC and downstream effectors that are intimately related to the exocytotic process (37,38). As CNP-evoked amylase release was mediated by NPR-C receptors experiments were performed in order to determine the intracellular signaling activated by CNP. Acini were pretreated with different inhibitors before the addition of the peptide.
Results showed that CNP-induced amylase release was abolished in the presence of U-73122 (PLC inhibitor) and 2-APB (IP 3 receptor inhibitor) and it was partially inhibited by GF-109203X (PKC inhibitor) (Fig. 6A) . However, CNP-evoked amylase secretion resulted unaltered by pretreatment with H-89 (PKA inhibitor) or KT-5823 (PKG inhibitor) (data not shown), supporting that CNP response was mediated by the activation of the PLC pathway and downstream effectors as observed for other secretagogues like CCK and carbachol.
Ryanodine pretreatment did not affect basal or CNP-evoked amylase release showing that CNP did not stimulate ryanodine receptors which are involved in the calcium signal propagation across the acinar cell (30) (Fig. 6B) .
To support the activation of PLC by CNP, phosphoinositide turnover was assessed.
CNP concentration-dependently enhanced phosphoinositide hydrolysis in isolated pancreatic acini but the increase was abolished in the presence of U-73122 indicating PLC Page 12 of 37 activation (Fig. 7) . The response was mimicked by the selective agonist cANP (4-23 amide)
(data not shown) further supporting NPR-C activation.
As the NPR-C receptor is also coupled to AC inhibition (2), cAMP content was assessed. CNP at 1 and 10 pM did not modify basal cAMP intracellular levels but at 1, 10
and 100 nM it concentration-dependently reduced them (Fig. 8) . The inhibition of cAMP was abolished by U-73122 (PLC inhibitor) and GF-109203X (PKC inhibitor) ( Fig. 9A and   9B , respectively). Pretreatment with either KT-5823 or L-NAME failed to affect CNP response (data not shown).
Cyclic GMP levels were also assessed in the presence of CNP because although the peptide binds to the NPR-C receptor, it is also a ligand for the NPR-B receptor (28) , which is expressed in pancreatic acini as shown in the present study. In addition, increases in cGMP content induced by this natriuretic peptide have been reported in various tissues and cell types (28) . The intracellular levels of cGMP were not affected by CNP at 1 and 10 pM but were increased by 1, 10 and 100 nM CNP showing a concentration biphasic effect, reaching the maximum at 10 nM (Fig. 10) . It is known that acute activation of G i/0 coupled receptors inhibits cAMP accumulation (6, 33) . The membrane-bound isoforms of AC are widely distributed and differentially regulated by protein kinases and calcium (6, 9) .
Discussion
The increase of cGMP was not unexpected since we showed that guanylyl cyclase coupled receptors were expressed in acinar cells. Furthermore, increased cGMP in response to ANF has been reported in the pancreas (10), as well as in response to CNP in other tissues (29) . The increase in cGMP supports NPR-A and/or NPR-B receptor activation although these receptors were not involved in CNP-evoked amylase secretion as previously discussed. The stimulation of cGMP showed a biphasic response possibly related to receptor desensitization induced by increased PKC activity mediated by NPR-C since this kinase mediates the heterologous desensitization of natriuretic peptide receptors coupled to guanylyl cyclase (21). Secretagogues that increase intracellular calcium levels also increase cGMP content but current evidence supports that this messenger is not directly involved in the triggering of the exocytotic process in the exocrine pancreas but in the modulation of calcium entry across the cell membrane (19,20). Whether CNP-induced cGMP is involved in the regulation of amylase release in the exocrine pancreas remains to be elucidated.
We reported that ANF also stimulates pancreatic fluid and protein secretion in vivo through the activation of NPR-C receptors coupled to the PLC pathway but without affecting AC signaling unless stimulated by secretin or VIP (27, 24) . These findings indicate that, although both natriuretic peptides modulate exocrine pancreatic secretion, the underlying mechanisms are different.
In the present study we showed that the three natriuretic peptide receptors were expressed in the rat exocrine pancreas. Although guanylyl cyclase coupled receptors expression was reported in human pancreas the presence of NPR-C receptors has not been demonstrated in this tissue (11) . Therefore whether the effect of CNP on amylase release through NPR-C activation occurs also in humans is presently unknown.
In conclusion, the present study shows that the three natriuretic peptide receptors 
